Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Feb 16, 2013; 5(2): 62-66
Published online Feb 16, 2013. doi: 10.4253/wjge.v5.i2.62
Table 1 Colonoscopy completion rates, patient demographics, sedation doses, procedure times and comfort scores in the Olympus Lucera and Pentax HiLine groups
IndicatorOlympus LuceraPentax HiLineP value
n (% of total)1
Complete colonoscopies413/425 (97.2)55/58 (94.9)0.24
Male patients239/413 (57.9)35/55 (63.7)0.5
mean ± SD2
Patient age (yr)66.3 ± 4.365.8 ± 4.70.36
Fentanyl dose (μg)57.5 ± 18.061.4 ± 18.50.13
Midazolam dose (mg)2.1 ± 0.62.4 ± 0.70.035
Comfort score0.49 ± 0.60.95 ± 0.6< 0.0001
Insertion time (min)11.1 ± 6.611.6 ± 7.50.93
Normal colonoscopy withdrawal time (min)15.6 ± 8.214.7 ± 8.00.20
Table 2 Polyp and adenoma detection rates in the Olympus Lucera and Pentax HiLine groups
Olympus LuceraPentax HiLineP value
With ≥ 1 polyp239/413 (58%)37/55 (67%)0.19
With ≥ 1 adenoma202/413 (49%)31/55 (56%)0.3
Table 3 Polyps and adenomas of various characteristics in the Olympus Lucera and Pentax HiLine groups (mean ± SD)
Size locationOlympus LuceraPentax HiLineP value
nmean ± SDnmean ± SD
Polyps
All5861.42 ± 1.96871.58 ± 1.730.19
> 1 cm1090.26 ± 0.53160.29 ± 0.500.51
≤ 1 cm4771.15 ± 1.78701.27 ± 1.580.27
≤ 0.5 cm3680.89 ± 1.53540.98 ± 1.270.22
Adenomas
All4141.00 ± 1.54591.07 ± 1.270.27
Proximal1640.4 ± 0.9210.38 ± 0.70.74
> 1 cm970.23 ± 0.50140.25 ± 0.480.6
≤ 1 cm3170.77 ± 1.38450.82 ± 1.110.29
≤ 0.5 cm2290.55 ± 1.13310.56 ± 0.960.63
Advanced adenomas
All1450.35 ± 0.7160.29 ± 0.50.64